Literature DB >> 16501222

Amyloid beta-protein monomer structure: a computational and experimental study.

Andrij Baumketner1, Summer L Bernstein, Thomas Wyttenbach, Gal Bitan, David B Teplow, Michael T Bowers, Joan-Emma Shea.   

Abstract

The structural properties of the Abeta42 peptide, a main constituent of the amyloid plaques formed in Alzheimer's disease, were investigated through a combination of ion-mobility mass spectrometry and theoretical modeling. Replica exchange molecular dynamics simulations using a fully atomic description of the peptide and implicit water solvent were performed on the -3 charge state of the peptide, its preferred state under experimental conditions. Equilibrated structures at 300 K were clustered into three distinct families with similar structural features within a family and with significant root mean square deviations between families. An analysis of secondary structure indicates the Abeta42 peptide conformations are dominated by loops and turns but show some helical structure in the C-terminal hydrophobic tail. A second calculation on Abeta42 in a solvent-free environment yields compact structures turned "inside out" from the solution structures (hydrophobic parts on the outside, polar parts on the inside). Ion mobility experiments on the Abeta42 -3 charge state electrosprayed from solution yield a bimodal arrival time distribution. This distribution can be quantitatively fit using cross-sections from dehydrated forms of the three families of calculated solution structures and the calculated solvent-free family of structures. Implications of the calculations on the early stages of aggregation of Abeta42 are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16501222      PMCID: PMC2249763          DOI: 10.1110/ps.051762406

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  40 in total

1.  Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates.

Authors:  D M Walsh; D M Hartley; Y Kusumoto; Y Fezoui; M M Condron; A Lomakin; G B Benedek; D J Selkoe; D B Teplow
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

2.  Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide.

Authors:  T H Huang; D S Yang; N P Plaskos; S Go; C M Yip; P E Fraser; A Chakrabartty
Journal:  J Mol Biol       Date:  2000-03-17       Impact factor: 5.469

3.  Atomic simulations of protein folding, using the replica exchange algorithm.

Authors:  Hugh Nymeyer; S Gnanakaran; Angel E García
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

Review 4.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

5.  On the nucleation of amyloid beta-protein monomer folding.

Authors:  Noel D Lazo; Marianne A Grant; Margaret C Condron; Alan C Rigby; David B Teplow
Journal:  Protein Sci       Date:  2005-06       Impact factor: 6.725

6.  The influence of different treatments of electrostatic interactions on the thermodynamics of folding of peptides.

Authors:  Andrij Baumketner; Joan-Emma Shea
Journal:  J Phys Chem B       Date:  2005-11-17       Impact factor: 2.991

7.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Authors:  M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

8.  Amyloid fibril formation by A beta 16-22, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR.

Authors:  J J Balbach; Y Ishii; O N Antzutkin; R D Leapman; N W Rizzo; F Dyda; J Reed; R Tycko
Journal:  Biochemistry       Date:  2000-11-14       Impact factor: 3.162

Review 9.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

10.  1H NMR of A beta amyloid peptide congeners in water solution. Conformational changes correlate with plaque competence.

Authors:  J P Lee; E R Stimson; J R Ghilardi; P W Mantyh; Y A Lu; A M Felix; W Llanos; A Behbin; M Cummings; M Van Criekinge
Journal:  Biochemistry       Date:  1995-04-18       Impact factor: 3.162

View more
  83 in total

1.  Aβ(39-42) modulates Aβ oligomerization but not fibril formation.

Authors:  Megan Murray Gessel; Chun Wu; Huiyuan Li; Gal Bitan; Joan-Emma Shea; Michael T Bowers
Journal:  Biochemistry       Date:  2011-12-23       Impact factor: 3.162

2.  Solid-support electron paramagnetic resonance (EPR) studies of Aβ40 monomers reveal a structured state with three ordered segments.

Authors:  Lei Gu; Sam Ngo; Zhefeng Guo
Journal:  J Biol Chem       Date:  2012-01-25       Impact factor: 5.157

3.  Investigating how peptide length and a pathogenic mutation modify the structural ensemble of amyloid beta monomer.

Authors:  Yu-Shan Lin; Gregory R Bowman; Kyle A Beauchamp; Vijay S Pande
Journal:  Biophys J       Date:  2012-01-18       Impact factor: 4.033

4.  Distinguishing amyloid fibril structures in Alzheimer's disease (AD) by two-dimensional ultraviolet (2DUV) spectroscopy.

Authors:  A R Lam; J Jiang; S Mukamel
Journal:  Biochemistry       Date:  2011-10-20       Impact factor: 3.162

5.  Polymorphic C-terminal beta-sheet interactions determine the formation of fibril or amyloid beta-derived diffusible ligand-like globulomer for the Alzheimer Abeta42 dodecamer.

Authors:  Buyong Ma; Ruth Nussinov
Journal:  J Biol Chem       Date:  2010-09-16       Impact factor: 5.157

6.  Discriminating early stage A{beta}42 monomer structures using chirality-induced 2DIR spectroscopy in a simulation study.

Authors:  Wei Zhuang; Nikolaos G Sgourakis; Zhenyu Li; Angel E Garcia; Shaul Mukamel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

7.  Role of Species-Specific Primary Structure Differences in Aβ42 Assembly and Neurotoxicity.

Authors:  Robin Roychaudhuri; Xueyun Zheng; Aleksey Lomakin; Panchanan Maiti; Margaret M Condron; George B Benedek; Gal Bitan; Michael T Bowers; David B Teplow
Journal:  ACS Chem Neurosci       Date:  2015-10-19       Impact factor: 4.418

8.  Multiple gas-phase conformations of proline-containing peptides: is it always cis/trans isomerization?

Authors:  Christopher B Lietz; Zhengwei Chen; Chang Yun Son; Xueqin Pang; Qiang Cui; Lingjun Li
Journal:  Analyst       Date:  2016-08-02       Impact factor: 4.616

Review 9.  The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes.

Authors:  Iryna Benilova; Eric Karran; Bart De Strooper
Journal:  Nat Neurosci       Date:  2012-01-29       Impact factor: 24.884

10.  Human islet amyloid polypeptide monomers form ordered beta-hairpins: a possible direct amyloidogenic precursor.

Authors:  Nicholas F Dupuis; Chun Wu; Joan-Emma Shea; Michael T Bowers
Journal:  J Am Chem Soc       Date:  2009-12-30       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.